O

Ocular Therapeutix
D

OCUL

12.620
USD
-0.02
(-0.12%)
مغلق
حجم التداول
57,439
الربح لكل سهم
-2
العائد الربحي
-
P/E
-10
حجم السوق
2,195,819,689
أصول ذات صلة
ABBV
ABBV
2.030
(0.99%)
206.710 USD
A
ACAD
0.820
(3.35%)
25.330 USD
A
AVDL
0.200
(1.48%)
13.690 USD
BMY
BMY
0.645
(1.35%)
48.465 USD
JNJ
JNJ
1.930
(1.10%)
176.650 USD
REGN
REGN
14.73
(2.60%)
580.63 USD
المزيد
الأخبار المقالات

العنوان: Ocular Therapeutix

القطاع: Healthcare
الصناعة: Biotechnology
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.